Clinical Trial Update: A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase II study of FH-006 for injection in combination with other anticancer therapies for lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• FH-006

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Lung Cancer | Phase 2 | Status: RECRUITING